Bio-Rad Laboratories, Inc.BIONYSE
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank46
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P46
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -6.78% |
| Q3 2025 | -13.88% |
| Q2 2025 | 225.32% |
| Q1 2025 | -59.37% |
| Q4 2024 | -9.52% |
| Q3 2024 | -36.48% |
| Q2 2024 | 95.15% |
| Q1 2024 | -46.82% |
| Q4 2023 | 7.52% |
| Q3 2023 | 1.49% |
| Q2 2023 | 44.75% |
| Q1 2023 | -47.83% |
| Q4 2022 | 27.88% |
| Q3 2022 | -22.81% |
| Q2 2022 | -17.89% |
| Q1 2022 | 36.85% |
| Q4 2021 | -31.77% |
| Q3 2021 | 25.66% |
| Q2 2021 | 23.72% |
| Q1 2021 | -42.44% |
| Q4 2020 | 59.89% |
| Q3 2020 | 111.82% |
| Q2 2020 | -30.43% |
| Q1 2020 | 25.62% |
| Q4 2019 | 3.04% |
| Q3 2019 | 1.90% |
| Q2 2019 | -0.38% |
| Q1 2019 | 124.36% |
| Q4 2018 | -740.53% |
| Q3 2018 | -17.17% |
| Q2 2018 | 0.33% |
| Q1 2018 | -7.26% |
| Q4 2017 | 1.47% |
| Q3 2017 | 2072.74% |
| Q2 2017 | -109.20% |
| Q1 2017 | 210.40% |
| Q4 2016 | -182.41% |
| Q3 2016 | 24.72% |
| Q2 2016 | -12.45% |
| Q1 2016 | -56.75% |